Stan, there is a world of difference between
tagatose and all the other sugar subsitutes, it's
those difference which give BINC somewhat of an
unlimited potential.
Firstly, tagatose is a full bulk substitue,
whereby it can be used in exactly the same
proportions as sugar in any and all recipes.
Secondly, it has absolutely no aftertaste and
tastes exactly like sugar.
Thirdly, it is naturally occuring in nature
and is derived from whey, a milk byproduct.
Additionally, it is actually a benefit to
diabetics and is said to be an appetite
suppresant.
If you consider the value of say a Hersheys
or a Kelloggs using tagatose the amount of
the contracts would be huge.
Lastly, while MDFI owns the license to
put tag in foods, BINC still owns the rights
for any medicinal uses.
I would not be surprised to see it used in candy,
ice cream, diet soft drinks and much more.
The bottom line is that once it's totally approved
and production ramped, BINC is easily looking
at something like 8 bucks a share or more in
revenues and no expenses. For the sake of
discussion, let's say BINC has 5 bucks a year
in revs starting in maybe the second or third
year of production, given a PE of maybe 9 or 10
and still growing, you can see the future of BINC.
J |
